Tumor Viruses: Infection, Carcinogenesis, and Treatment
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: 30 January 2026 | Viewed by 14
Special Issue Editor
Interests: gene; infectious diseases; herpesviruses; pharmacology and toxicology; molecular medicine; oncology and hematology; cardiovascular diseases; natural products; drug discovery; analytical and bioanalytical techniques
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tumor viruses represent a significant class of pathogens that contribute to human malignancies by establishing persistent infections, modulating host immune responses, and disrupting normal cellular processes through genetic and epigenetic mechanisms. Several viruses—including Epstein–Barr virus (EBV), human papillomavirus (HPV), hepatitis B and C viruses (HBV and HCV), human T-cell leukemia virus type 1 (HTLV-1), Kaposi’s sarcoma-associated herpesvirus (KSHV), and Merkel cell polyomavirus (MCPyV)—are well-established human oncogenic viruses. In addition, a growing number of viruses are being investigated for their potential roles in tumor initiation and progression, warranting broader exploration.
This Special Issue will delve into the multifaceted roles of tumor viruses in carcinogenesis, with a focus on key processes such as viral latency, immune evasion, oncogene expression, and the hijacking of host signaling pathways. We will also highlight state-of-the-art developments in the diagnosis, prevention, and treatment of virus-associated cancers. This includes progress in antiviral drug development, therapeutic and prophylactic vaccines, immune-based therapies, and innovative gene-editing technologies such as CRISPR/Cas systems.
We invite the submission of original research articles, comprehensive reviews, communications, and perspective papers that advance our understanding of tumor viruses and their role in oncogenesis. Submissions that support translational research, clinical innovation, or public health impact are particularly encouraged. This Special Issue aims to foster a multidisciplinary dialogue in oncogenic virology and promote the development of novel strategies for the management of virus-associated malignancies.
Dr. Sherif T.S. Hassan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor viruses
- viral oncogenesis
- EBV, HPV, KSHV, HBV, HCV, HTLV-1, and MCPyV
- virus-associated cancers
- merging oncoviruses
- viral latency
- immune evasion
- antiviral therapy
- immunotherapy
- cancer vaccines
- gene-editing technologies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
